All known DNA polymerases require primers for the initiation of DNA synthesis. While cellular polymerases and reverse transcriptases use free hydroxyl groups of RNA or DNA, the DNA polymerases of certain animal viruses and bacteriophages depend upon hydroxyl groups of amino acid residues within proteins as primers for DNA synthesis. Recently, the reverse transcriptase of a hepadnavirus has been shown to prime RNA-directed DNA synthesis from an internal site of the polypeptide (G. H. Wang and C. Seeger, Cell 71:663-670, 1992 728-3616. been proposed which assigns primer function to the aminoterminal domain (also termed terminal protein) and reverse transcriptase and RNase H functions to the central and carboxy-terminal regions of the polypeptide, respectively (4, 7, 29, 37) . Furthermore, primer and reverse transcriptase domains appear to be linked by a tether region or spacer which tolerates amino acid substitution and deletions (4, 7, 29) .
DNA polymerases require primers for the initiation of DNA synthesis. While cellular DNA polymerases use the 3' hydroxyl groups of short RNA oligomers synthesized by DNA primases for this reaction, viral and phage polymerases have adopted a variety of strategies to initiate genome replication (18, 23) . For example, the reverse transcriptases of retroviruses use tRNAs as primers for RNA-directed DNA synthesis (33) . In other systems, priming reactions utilize 3' hydroxyl groups that become available following the nicking of DNA or after the formation of DNA hairpins (18) . Finally, some DNA polymerases use hydroxyl groups in amino acid residues of polypeptides as primers for DNA synthesis (32, 39) . The role of protein as a primer for DNA synthesis has so far been demonstrated for adenoviruses and the bacteriophages 4)29, CP-1, and PRD1 (2, 9, 13, 21) . In the case of adenoviruses, the terminal protein forms a complex with the viral DNA polymerase which interacts with the origin of DNA replication by recognition of specific sequences at the ends of the viral genome (34) .
Hepadnaviruses, which replicate their DNA genomes by reverse transcription of an RNA intermediate, also contain a protein covalently linked to viral DNA (11, 35) . On the basis of the adenovirus model, it has been suggested that this protein could function as a primer for DNA synthesis (11) . Evidence in support of this hypothesis was provided by the observation that short nascent viral DNA species present in subviral core particles of infected hepatocytes are covalently linked to protein through the first nucleotide of minus-strand DNA, dGMP (22, 25, 26) . Furthermore, evidence was provided that this protein was of viral origin, since viral DNA present in subviral core particles could be immunoprecipitated with antibodies directed against peptides that correspond to the predicted amino acid sequence of the polymerase polypeptide (4) . These experiments also suggested that the amino-terminal domain of the polymerase may bear the site at which DNA is attached (4) . On the basis of these and other results, a structural organization of the polymerase gene product has been proposed which assigns primer function to the aminoterminal domain (also termed terminal protein) and reverse transcriptase and RNase H functions to the central and carboxy-terminal regions of the polypeptide, respectively (4, 7, 29, 37) . Furthermore, primer and reverse transcriptase domains appear to be linked by a tether region or spacer which tolerates amino acid substitution and deletions (4, 7, 29) .
Recently, we demonstrated that the polymerase of duck hepatitis B virus (DHBV) synthesized in an in vitro translation reaction exhibits reverse transcriptase activity and that the viral polymerase acts as a primer for DNA synthesis (40) . With (24, 28) . Plasmid pHP is a derivative of plasmid pGal5.1 in which a fragment spanning positions 1 to 172 has been replaced with a 33-nucleotide DNA fragment that contains the leader sequence of brome mosaic virus RNA 5 and a sequence coding for six histidine residues (see Fig. 1A ). Plasmid pHTP is a derivative of plasmid pHP with a substitution of sequences spanning nucleotides 846 to 919 with a 64-nucleotide synthetic linker that contains sequences coding for the thrombin cleavage site (12) . The construction of plasmids pK99T and pY96F was carried out by oligomer-directed site-specific mutagenesis as described previously (19) , with the help of single-stranded uracil-containing pUC119 DHBV 7.2, kindly provided by J. Summers. Plasmid pK99T bears an A-to-C mutation at position 469 in the polymerase gene, which changes lysine 99 to threonine, while plasmid pY96F bears an A-to-T mutation at position 460 (30) . The digested material was subjected to electrophoresis through SDS-23% polyacrylamide gels.
RESULTS Experimental strategy. Previously we have shown that the 95-kDa product of the DHBV polymerase gene, synthesized in a reticulocyte lysate, can incorporate a-32P-labelled deoxynucleoside triphosphates in a reaction that requires viral RNA and magnesium (40) . Subsequent experiments have shown that incorporation of the first nucleotide, dGMP, is directed by an rC residue at position 2576 in the 3' copy of the hairpin structure of the RNA packaging signal s, as shown in Fig. 1A (41) . To conduct the study reported here, we constructed a vector, termed pHP, for the expression of a modified DHBV polymerase polypeptide which bears six histidine residues at its amino terminus (Fig. 1A ). This modification allowed the purification of the polymerase, following in vitro translation and incubation with dGTP, from the reticulocyte lysate through the ability of the six histidine residues to bind to nickel ions immobilized on an NTA resin (see Materials and Methods). The modified polymerase polypeptide had an estimated molecular mass of 95 kDa and displayed enzymatic activities comparable to those of the wild-type protein ( Following this reaction, the modified polypeptide could be purified with the help of the Ni-NTA resin (Fig. iB , lanes 3 to 6). In addition to the major translation product, a second protein with an estimated molecular mass of 35 kDa was routinely observed and was also retained on the Ni-NTA resin. This polypeptide most likely represents a proteolytic product derived from the amino terminus of the polymerase that contains the inserted histidine residues. Purification of the polymerase polypeptide with the Ni-NTA resin strictly depended on the presence of the six histidine residues on the polymerase (data not shown).
A tyrosine residue of the reverse transcriptase is attached to DNA. Known phosphodiester linkages between viral proteins and the 5' ends of DNA or RNA require the hydroxyl group of either serine, threonine, or tyrosine (32, 39) . While phosphate in phosphotyrosine is generally resistant to base hydrolysis, phosphoserine and phosphothreonine bonds are cleaved under these conditions (8) . To characterize the bond between the DHBV polymerase and dGMP, we incubated the 32P-labelled polymerase polypeptide in 1 M KOH at 55°C for 2 h following electrophoresis through an acrylamide-SDS gel (8) . Under these conditions the polymerase polypeptide appeared to retain radioactivity, consistent with the interpretation that the linkage between the polymerase and dGMP occurred through a tyrosine residue ( Fig. 2A) . This interpretation was in agreement with previous observations which demonstrated that the linkage between viral DNA and protein of hepatitis B viruses resisted cleavage in strong alkali (4, 11, 26) .
To prove that the DNA-protein bond indeed involves a tyrosine residue of the polymerase gene product, 32P-labelled polymerase polypeptides were purified from the lysate and subjected to hydrolysis in 6 N HCl. Two-dimension thin-layer analysis of the liberated phosphoamino acids revealed the presence of radioactive phosphotyrosine (Fig. 2B) . A second product with a low mobility in the first electrophoretic dimension may represent a partial hydrolysis product. Similar products have previously been observed in experiments performed with DNA-protein complexes derived from bacteriophages PRD1 and Cp-1 (2, 9) .
These results thus demonstrated that the polymerase gene product of DHBV is covalently attached to dGMP through a phosphodiester bond that involves a tyrosine residue of the polymerase polypeptide.
The tyrosine residue is located in the amino-terminal domain of the DHBV polymerase. Since a radioactively labelled 35-kDa protein fragment was able to bind to the Ni-NTA resin (Fig. IB, lane 6) , we expected that a tyrosine residue in the amino-terminal domain of the polymerase was linked to dGMP. To confirm this interpretation, we digested the polymerase-dGMP complex with thrombin and isolated the resulting proteolytic fragments with the Ni-NTA resin. The polymerase polypeptide used for this experiment contained a synthetic thrombin cleavage site at amino acid 235 (pHTP), which was inserted into the tether region of the polymerase (Fig. 3A) . As expected, the polypeptide could be labelled following incubation with [32P]dGTP (Fig. 3B, lane 2) . Following incubation with thrombin, the proteolytic fragments bearing the six histidine residues at their amino termini were purified with the Ni-NTA resin and subjected to gel electrophoresis (Fig. 3B, lanes 7 and 8) . The analysis of the eluted proteolytic products revealed a fast-migrating doublet with apparent molecular masses of 18 and 20 kDa and an additional product with an apparent molecular mass of 30 kDa (Fig. 3B,  lane 8) (Fig. 4, lanes 4, 8, and 10 ). Another polymerase variant was created in which tyrosine 96 is changed to serine. This variant, termed Y96S, also lost its ability to incorporate dGMP (Fig. 4 Proteolytic mapping of the tyrosine residue linked to dGMP. To verify that tyrosine 96 is indeed the site of the linkage with the 5' end of the minus strand, we generated a polymerase variant in which lysine 99 was substituted for threonine. This mutation eliminates a recognition site for both trypsin and endoproteinase Lys-C adjacent to tyrosine 96 (Fig. SA) . This variant, termed K99T, remained competent for the priming reaction (Fig. SB) 4) were electrophoresed through an SDS-12% polyacrylamide gel. The gel slice depicting lanes 3 and 4 was soaked in two changes of 10% acetic acid-10% isopropanol and then incubated in 15 volumes of I M KOH at 55°C for 2 h as previously described (8) . The gel was neutralized, dried, and autoradiographed. (B) Phosphoamino acid analysis of dGMP-labelled polymerase polypeptides. Purified polymerase polypeptides were hydrolyzed in 6 N HCI at 110°C for 60 min. The products obtained from this reaction were analyzed by two-dimensional thin-layer analysis with electrophoresis in pH 3.5 buffer for the first dimension; this was followed by chromatography for the second dimension. The positions of the unlabelled phosphoamino acids markers stained with ninhydrin are indicated. x, origin
Tryptic digests were performed under mild denaturing conditions after the purification of the polymerase polypeptide. A comparison of the tryptic peptide patterns on an SDS-24% polyacrylamide gel, obtained with the wild-type polymerase and the K99T mutant, showed that the amino acid change at position 99 induced a shift in the electrophoretic mobility of the smallest radioactive tryptic peptide, as expected if tyrosine 96 was linked to [32P]dGMP (Fig. 5C ). Additional larger proteolytic peptides were observed and most likely represented proteolytic products derived from incomplete digestion. In particular, the 17-aa species produced after elimination of a trypsin site in the K99T variant was also observed with the wild-type polymerase but only as a very faint band. To ensure that the shifted peptide was indeed the smallest tryptic peptide, these proteolytic products were also electrophoresed through a 40% polyacrylamide alkaline gel, which is known to resolve phosphopeptides with molecular masses below 3 kDa according to charge and mass (42), and the same result was obtained (data not shown).
In an attempt to circumvent the problem of the incomplete digestion observed with trypsin, we digested the polymerase polypeptide with endoproteinase Lys-C, which specifically cleaves peptide bonds C terminally at lysine residues and has also been reported to be active in high concentrations of urea (30) . A comparison of the proteolytic peptide patterns obtained with the wild-type polymerase and the K99T mutant again showed that the amino acid change at position 99 induced a shift in the electrophoretic mobility of the smallest radioactive peptide (Fig. 5D) , consistent with the interpretation that tyrosine 96 is the site of the covalent bond with dGMP. Additional larger polypeptides, most likely related to a partial digestion of the substrate, were observed with the same pattern in both the wild-type and the mutant polymerases.
Hence, these results were in good agreement with the observations described in the previous section, which identify tyrosine 96 of the polymerase polypeptide as the residue covalently linked to the 5' end of minus-strand DNA.
DISCUSSION
In this report, we have established that the DHBV polymerase uses a specific tyrosine residue in its amino-terminal domain for the initiation of reverse transcription. Following purification of the polymerase-DNA complex, we employed biochemical and genetic strategies which independently led to the identification of the tyrosine residue responsible for the phosphodiester bond between the DHBV polymerase and the first nucleotide of minus-strand DNA (Fig. 3, 4 , and 5). These results are in good agreement with previous attempts to characterize the linkage between the hepadnaviral polymerase and viral DNA in subviral core particles (4, 11, 26) .
The polymerase of hepatitis B viruses is the first known reverse transcriptase that uses protein as a primer for DNA synthesis. The protein priming of viral genome replication has so far been described for adenoviruses and certain bacteriophages (32, 39) . In all known instances in which protein acts as a primer for DNA synthesis, the activities required for priming and DNA polymerization reside on two separate molecules and the initiation of genome replication requires the interaction between the two components, the terminal protein and the polymerase at the origin of DNA replication (32, 39) . By contrast, in hepadnaviruses, the primer and polymerase domains reside on the same molecule (Fig. 1) . This observation is in agreement with the results reported by Bartenschlager and colleagues (3), which suggested that the polymerase expressed by HBV in tissue culture cells may also act as an unprocessed polypeptide.
As shown in this report, the protein-DNA bond in hepadnavirus involves a tyrosine residue (Fig. 2) . While the amino acids serine and threonine could potentially act as targets for the priming reaction, our results indicated that the incorporation of dGMP strictly depended on the tyrosine residue at position 96, which could not be substituted by serine (Fig. 4) . Similar proteins of bacteriophage +29 and adenovirus, which depend uipon specific serine residues for the formation of a bond with DNA (10, 27) . Tyrosine residues have been identified in several other instances as substrates for the formation of phosphodiester linkages, as, for example, with bacteriophage PRDI, the gene A protein of bacteriophage 4X174, and VPg of poliovirus (2, 31, 36) . Tyrosine residues can play a crucial role in enzymes which display a DNA nicking-closing activity, as described for DNA topoisomerases (38). Similarly, the tyrosyl bond that we have characterized for the DHBV polymerase may be critical in the reaction which converts relaxed circular virion DNA into covalently closed circular DNA, following penetration of the virus into infected cells. This reaction requires the removal of the polymerase from the 5' end of the minus-strand DNA and the ligation of the 5' and 3' ends of the viral DNA. It will be interesting to see whether the hepadnaviral polymerase, alone or in association with cellular DNA-modifying enzymes, is involved in the catalysis of this reaction. While the nature of the linkage between the polymerase and DNA is conserved with respect to the amino acid residue, it appears to be flexible with respect to the nucleotide attached to tyrosine. This experiments that indicated that the incorporation of the first nucleotide into the polypeptide occurs in a template-dependent reaction and that the polymerase has the ability to accept deoxynucleoside monophosphates other than dGMP (41) .
On the basis of the results presented in this report, we can envision a model for the initiation of reverse transcription which predicts that the hydroxyl group of tyrosine 96 of the polymerase reaches into the active site of the reverse transcriptase and provides the substrate for the formation of the phophodiester linkage with dGMP. This complex then provides the substrate for the continuation of DNA synthesis. How the amino-terminal domain changes its configuration as DNA synthesis progresses is not known. It will be also important to determine whether a single polymerase polypeptide has the ability to synthesize the complete viral DNA genome. Since structural and functional analyses of the human immunodeficiency virus reverse transcriptase have shown that this enzyme forms a heterodimer (15, 17) , it is conceivable that the hepadnaviral enzyme might also function as a dimer. In fact, we attempted to assess whether the DHBV polymerase functions as a dimer and assayed two variants of this enzyme, with mutations at the site for priming of DNA synthesis (Y96F) and at the conserved YMDD motif within the catalytic core of the reverse transcriptase domain (7), for their potential to complement each other. Our results suggest that complementation does not occur under our selected conditions (43). These results also suggest that, under our in vitro conditions, the DHBV polymerase may function as a monomer and that the presence of an active reverse transcriptase domain is necessary for the priming activity.
In summary, with the results presented in this report, we have gained an important insight into the unique mechanism employed by the reverse transcriptase of hepadnaviruses for the initiation of RNA-directed DNA synthesis. Since the formation of a covalent linkage between the polymerase and DNA is an essential step for genome replication, this reaction could provide an attractive target for the development of antiviral therapies. 
